Literature DB >> 28480766

Follicular lymphomas and their transformation: Past and current research.

Miriam Mendez1, Maria Torrente1, Mariano Provencio1.   

Abstract

INTRODUCTION: Follicular lymphoma (FL) is the second most common type of non-Hodgkin lymphoma (NHL). Histological transformation (HT) refers to the evolution of a clinically indolent NHL to a clinically aggressive one, defined as those lymphomas in which survival is limited to a few months when untreated. Areas covered: HT is associated with rapid progression of lymphadenopathy, infiltration of extranodal sites, development of systemic symptoms, and elevated serum level of lactate dehydrogenase (LDH). It is frequently related to a poor prognosis, and the median survival after transformation is less than 2 years. Transformation to diffuse large B cell lymphoma (DLBCL) in patients with FL occurs at an annual rate of approximately 3% for the first 15 years, after which the risk of HT falls for reasons that remain unclear. Expert commentary: Although it has long been assumed that transformation reflects the emergence of an aggressive subclone of cells from the primary FL, recent studies suggest that FL transformation might also arise by divergent evolution from a more immature common progenitor cell. Studies on genomic changes and DNA sequencing have shed some light onto the process of transformation. Nowadays, we know that HT is a complex process where several molecular pathways are involved.

Entities:  

Keywords:  Common progenitor cell; DNA sequencing; follicular lymphoma; genomic changes; histological transformation

Mesh:

Substances:

Year:  2017        PMID: 28480766     DOI: 10.1080/17474086.2017.1326812

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


  2 in total

1.  Fungating groin mass in a woman with a history of follicular lymphoma.

Authors:  Kunal Bailoor; Tony Chen
Journal:  BMJ Case Rep       Date:  2017-08-16

2.  PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.

Authors:  Marie Beck Enemark; Ida Monrad; Charlotte Madsen; Kristina Lystlund Lauridsen; Bent Honoré; Trine Lindhardt Plesner; Stephen Jacques Hamilton-Dutoit; Francesco d'Amore; Maja Ludvigsen
Journal:  Onco Targets Ther       Date:  2021-01-18       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.